Betty Peng

505 total citations
13 papers, 294 citations indexed

About

Betty Peng is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Betty Peng has authored 13 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Betty Peng's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (6 papers) and HIV/AIDS drug development and treatment (5 papers). Betty Peng is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (6 papers) and HIV/AIDS drug development and treatment (5 papers). Betty Peng collaborates with scholars based in United States and Italy. Betty Peng's co-authors include William E. Delaney, Guofeng Cheng, Tian Yang, Huiling Yang, Yu Mei, Ruoyu Gong, Amoreena C. Corsa, Nikos Pagratis, Hongmei Mo and John O. Link and has published in prestigious journals such as Gastroenterology, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Betty Peng

13 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Betty Peng United States	9	268	241	130	38	27	13	294
Lubna Ghanem Denmark	7	317 1.2×	284 1.2×	93 0.7×	27 0.7×	50 1.9×	7	344
Ellen Xia United States	9	271 1.0×	205 0.9×	167 1.3×	24 0.6×	35 1.3×	13	296
Sanne B. Jensen Denmark	8	312 1.2×	289 1.2×	91 0.7×	26 0.7×	60 2.2×	9	341
Evguenia Svarovskaia United States	7	328 1.2×	294 1.2×	139 1.1×	21 0.6×	7 0.3×	14	339
Katrien Vermeiren Sweden	4	285 1.1×	222 0.9×	170 1.3×	40 1.1×	29 1.1×	5	346
Rob Elston United States	5	292 1.1×	263 1.1×	103 0.8×	23 0.6×	6 0.2×	7	323
Linda Baher United States	3	277 1.0×	248 1.0×	81 0.6×	21 0.6×	6 0.2×	3	288
Krishna Chodavarapu United States	8	335 1.3×	292 1.2×	103 0.8×	27 0.7×	7 0.3×	10	346
Leonie Grellier United Kingdom	5	145 0.5×	132 0.5×	45 0.3×	22 0.6×	7 0.3×	6	189
S. Roberts Australia	10	276 1.0×	250 1.0×	69 0.5×	13 0.3×	4 0.1×	19	286

Countries citing papers authored by Betty Peng

Since Specialization

Citations

This map shows the geographic impact of Betty Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty Peng more than expected).

Fields of papers citing papers by Betty Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betty Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty Peng. The network helps show where Betty Peng may publish in the future.

Co-authorship network of co-authors of Betty Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Betty Peng. A scholar is included among the top collaborators of Betty Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betty Peng. Betty Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Cheng, Guofeng, Tian Yang, Brian Doehle, et al.. (2016). In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir. Antimicrobial Agents and Chemotherapy. 60(3). 1847–1853. 50 indexed citations

Mei, Yu, Betty Peng, Ruoyu Gong, et al.. (2014). Robust and Persistent Replication of the Genotype 6a Hepatitis C Virus Replicon in Cell Culture. Antimicrobial Agents and Chemotherapy. 58(5). 2638–2646. 24 indexed citations

Mei, Yu, Amoreena C. Corsa, Simin Xu, et al.. (2013). In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons. Antiviral Research. 100(2). 439–445. 17 indexed citations

Yang, Huiling, Margaret Robinson, Amoreena C. Corsa, et al.. (2013). Preclinical Characterization of the Novel Hepatitis C Virus NS3 Protease Inhibitor GS-9451. Antimicrobial Agents and Chemotherapy. 58(2). 647–653. 23 indexed citations

Cheng, Guofeng, Ming‐Jiun Yu, Betty Peng, et al.. (2013). 1191 GS-5816, A SECOND GENERATION HCV NS5A INHIBITOR WITH POTENT ANTIVIRAL ACTIVITY, BROAD GENOTYPIC COVERAGE AND A HIGH RESISTANCE BARRIER. Journal of Hepatology. 58. S484–S485. 38 indexed citations

Peng, Betty, Yu Mei, Simin Xu, et al.. (2012). Development of Robust Hepatitis C Virus Genotype 4 Subgenomic Replicons. Gastroenterology. 144(1). 59–61.e6. 30 indexed citations

Cheng, Guofeng, Betty Peng, Amoreena C. Corsa, et al.. (2012). 1172 ANTIVIRAL ACTIVITY AND RESISTANCE PROFILE OF THE NOVEL HCV NS5A INHIBITOR GS-5885. Journal of Hepatology. 56. S464–S464. 34 indexed citations

Cheng, Genhong, Martijn Fenaux, Eric Mabery, et al.. (2011). 1198 NUCLEOTIDE INHIBITOR RESISTANCE SELECTIONS USING GT2A INFECTIOUS VIRUS: PSI-7851 AND GS-6620 SELECT FOR A NOVEL RESISTANCE PATHWAY INCLUDING SUBSTITUTIONS OF M289V/L FOLLOWED BY S282T. Journal of Hepatology. 54. S473–S473. 7 indexed citations

Berry, Katherine E., Betty Peng, David Koditek, et al.. (2011). Optimized High-Throughput Screen for Hepatitis C Virus Translation Inhibitors. SLAS DISCOVERY. 16(2). 211–220. 8 indexed citations

10.

Corsa, Amoreena C., Margaret Robinson, Hai Yang, et al.. (2011). 778 PRECLINICAL PROPERTIES OF THE NOVEL HCV NS3 PROTEASE INHIBITOR GS-9451. Journal of Hepatology. 54. S313–S313. 4 indexed citations

11.

Robinson, Margaret, Huiling Yang, Betty Peng, et al.. (2010). Novel Hepatitis C Virus Reporter Replicon Cell Lines Enable Efficient Antiviral Screening against Genotype 1a. Antimicrobial Agents and Chemotherapy. 54(8). 3099–3106. 39 indexed citations

12.

Vliegen, Inge, Jan Paeshuyse, Eric Mabery, et al.. (2007). GS-9190, a novel substituted imidazo-pyridine analogue, is a potent inhibitor of hepatitis C virus replication in vitro and remains active against known drug-resistant mutants. 8 indexed citations

13.

Vliegen, Inge, Betty Peng, Hao Yang, et al.. (2007). Mechanistic characterization of GS-9190, a novel non-nucleoside inhibitor of HCV NS5B polymerase with potent antiviral activity and a unique mechanism of action. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact